IOL Chemicals and Pharmaceuticals Limited - Asset Resilience Ratio

Latest as of September 2025: 13.27%

IOL Chemicals and Pharmaceuticals Limited (IOLCP) has an Asset Resilience Ratio of 13.27% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Also explore IOLCP total asset value for the complete picture of this company's asset base.

Liquid Assets

Rs3.20 Billion

≈ $34.64 Million USD Cash + Short-term Investments

Total Assets

Rs24.13 Billion

≈ $260.97 Million USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2005–2025)

This chart shows how IOL Chemicals and Pharmaceuticals Limited's Asset Resilience Ratio has changed over time. See IOL Chemicals and Pharmaceuticals Limite net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down IOL Chemicals and Pharmaceuticals Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IOLCP stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs1.68 Billion	6.97%
Short-term Investments	Rs1.52 Billion	6.3%
Total Liquid Assets	Rs3.20 Billion	13.27%

Asset Resilience Insights

Moderate Liquidity: IOL Chemicals and Pharmaceuticals Limited has 13.27% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

IOL Chemicals and Pharmaceuticals Limited Industry Peers by Asset Resilience Ratio

Compare IOL Chemicals and Pharmaceuticals Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Guizhou Bailing Group Pharmaceutical Co Ltd SHE:002424	Drug Manufacturers - Specialty & Generic	2.09%
Dezhan HealthCare Co Ltd SHE:000813	Drug Manufacturers - Specialty & Generic	0.15%

Annual Asset Resilience Ratio for IOL Chemicals and Pharmaceuticals Limited (2005–2025)

The table below shows the annual Asset Resilience Ratio data for IOL Chemicals and Pharmaceuticals Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	5.50%	Rs1.31 Billion ≈ $14.18 Million	Rs23.82 Billion ≈ $257.61 Million	-0.50pp
2024-03-31	6.01%	Rs1.35 Billion ≈ $14.58 Million	Rs22.44 Billion ≈ $242.72 Million	+4.93pp
2023-03-31	1.08%	Rs217.50 Million ≈ $2.35 Million	Rs20.22 Billion ≈ $218.69 Million	-4.86pp
2022-03-31	5.94%	Rs1.17 Billion ≈ $12.60 Million	Rs19.62 Billion ≈ $212.22 Million	-13.89pp
2021-03-31	19.83%	Rs3.19 Billion ≈ $34.53 Million	Rs16.10 Billion ≈ $174.13 Million	+11.05pp
2020-03-31	8.78%	Rs1.03 Billion ≈ $11.11 Million	Rs11.70 Billion ≈ $126.51 Million	+8.77pp
2019-03-31	0.01%	Rs600.00K ≈ $6.49K	Rs9.42 Billion ≈ $101.86 Million	-2.03pp
2018-03-31	2.04%	Rs173.80 Million ≈ $1.88 Million	Rs8.52 Billion ≈ $92.15 Million	+0.03pp
2017-03-31	2.01%	Rs164.40 Million ≈ $1.78 Million	Rs8.17 Billion ≈ $88.41 Million	+2.01pp
2016-03-31	0.01%	Rs457.23K ≈ $4.94K	Rs7.76 Billion ≈ $83.91 Million	+0.00pp
2015-03-31	0.00%	Rs99.90K ≈ $1.08K	Rs7.02 Billion ≈ $75.88 Million	-1.20pp
2012-03-31	1.20%	Rs82.56 Million ≈ $892.83K	Rs6.87 Billion ≈ $74.29 Million	-1.02pp
2006-03-31	2.22%	Rs21.03 Million ≈ $227.45K	Rs946.52 Million ≈ $10.24 Million	+0.80pp
2005-03-31	1.42%	Rs8.55 Million ≈ $92.50K	Rs600.82 Million ≈ $6.50 Million	--

pp = percentage points

About IOL Chemicals and Pharmaceuticals Limited

NSE:IOLCP India Drug Manufacturers - Specialty & Generic

Market Cap

$417.11 Million

Rs38.57 Billion INR

Market Cap Rank

#13462 Global

#644 in India

Share Price

Rs131.40

Change (1 day)

-3.42%

52-Week Range

Rs68.21 - Rs136.06

All Time High

Rs840.03